<DOC>
	<DOCNO>NCT03102762</DOCNO>
	<brief_summary>To evaluate safety efficacy intra-cavernosal Botulinum toxin injection alternative line treatment patient erectile dysfunction - respond oral PDE5i - cavernosal smooth muscle relaxation .</brief_summary>
	<brief_title>Botulinum Toxin Erectile Dysfunction</brief_title>
	<detailed_description>The initial Phase 1 study demonstrate safety efficacy Botulinum toxin type A treatment Erectile dysfunction small randomize controlled trial 24 men . The investigator conduct phase 2 trial confirm initial result large group men.160 male include study . The participant subject full history taking , general genital examination . Penile duplex perform assess vascular etiology treatment 2 week later . The patient randomize treatment group ( 12 patient ) control group ( 12 patient ) . All patient sign inform consent . The treatment group inject IC trimix solution ( 20 ug alprostadil + 1 mg phentolamine + 30 mg papaverine ) color Doppler assessment , follow , next day 50 unit BTX-A . The control group , 12 patient , injected trimix solution penile color Doppler assessment follow next day normal saline injection . The erection hardness score ( EHS ) assess Doppler exam . Procedure : At least 1 day penile color Doppler test , patient place supine position flaccid stretch penile length girth would measure tip penis pubic bone do . A rubber band apply base penis . The skin prepped alcohol swab follow IC injection 100 unit BTX-A . Direct pressure apply 2 minute . The rubber band remove 15 minute . Patients control fill Sexual Health Inventory men ( SHIM ) questionnaire answer Sexual Encounter Profile question 1 2 ( SEP 2 &amp; SEP 3 ) , global assessment question ( GAQ ) 4 week treatment .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>160 male include study recruit Andrology , Sexology &amp; STD 's outpatient clinic , Kasr El Aini Hospitals , Cairo University , complain ED . Unable develop erection sufficient intercourse . Failing respond first line second line treatment Erectile Dysfunction surgery remain treatment option . Age 40 70 year . Significant cardiovascular disease interfere sexual activity</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Botulinum toxin A</keyword>
	<keyword>Botox</keyword>
</DOC>